Custom plastic implants for skull and face defects under scrutiny in new study
NCT ID NCT05362370
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is checking how safe and effective Stryker's custom-made PEEK implants are for fixing bone and soft tissue problems in the skull and face. About 99 people who need these implants will be followed for up to 24 months after surgery. The main goal is to see how often infections or other serious problems happen.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PEEK Customized Implant (a plastic-like medical device used to reconstruct bone defects in the skull and face)
What this could lead to
If successful, this could confirm that PEEK implants are a safe and effective option for repairing skull and facial bone defects, improving appearance and function.
What could go wrong
This is a post-market study, so the device is already approved. Risks include infection, implant failure, or serious side effects. The study is relatively small (99 people) and not randomized.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRANIOPLASTY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHP - Hôpital Lariboisière Neurochirurgie 2 rue Ambroise Paré
Paris, Paris France, 75010, France
-
CHU Nantes - Hopital Guillaume et Rene Laënnec, Cedex 1
Nantes, Pays de la Loire Region, 44093, France
-
Department of Neurological Surgery
New Brunswick, New Jersey, 07101-1709, United States
-
Department of Neurological Surgery, 710 West 168th Street, 4th Floor, New York Presbyterian Hospital
New York, New York, 10032, United States
-
Klinik für Neurochirurgie Klinikum Dortmund Münsterstr. 240
Dortmund, North Rhine-Westphalia, 44145, Germany
-
Lewis Katz School of Medicine at Temple University, 3401 North Broad Street
Philadelphia, Pennsylvania, 19140, United States
-
Medical University of South Carolina, Oral & Maxillofacial Surgery, 173 Ashley Avenue, Charleston, USA
Charleston, South Carolina, 29425, United States
-
Neurosurgery, Emergency and Major Trauma (NET) Research | Division of Medicine | Imperial College Healthcare NHS Trust
London, London, SW7 2AZ, United Kingdom
-
Pierre-Paul Riquet Hospital, Place du Docteur Baylac, Cedex 9
Toulouse, Occitanie, TSA 40031 - 31059, France
-
Servicio de Neurocirugía Hospital Universitario La Paz.
Madrid, Madrid, 28046, Spain
-
St. Barbara-Klinik Hamm GmbH Hamm Heessen und St. Josef-Krankenhaus Hamm-Bockum-Hövel Am Heessener Wald 1 | 1263
Hamm, Hamm, 59073, Germany
-
University of Louisville 501 E. Broadway, Suite 210
Louisville, Kentucky, 40202, United States
-
Universitätsklinik für Neurochirurgie Auenbruggerplatz 29
Graz, 8036, Austria